(Q37079123)

18 August 2017

1 reference

title

Amlodipine/Valsartan: fixed-dose combination in hypertension (English)

1 reference

18 August 2017

main subject

arterial hypertension

0 references

1

Greg L Plosker

1 reference

18 August 2017

Dean M Robinson

2

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

68

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

373-381

1 reference

Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease

18 August 2017

cites work

1 reference

12 December 2020

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome

1 reference

12 December 2020

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators

1 reference

12 December 2020

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

12 December 2020

Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies

1 reference

12 December 2020

The effects of valsartan on insulin sensitivity in patients with primary hypertension

1 reference

12 December 2020

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study

1 reference

12 December 2020

2007 Guidelines for the Management of Arterial Hypertension

1 reference

12 December 2020

Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients

1 reference

12 December 2020

Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients

1 reference

12 December 2020

Valsartan. A review of its pharmacology and therapeutic use in essential hypertension

1 reference

12 December 2020

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

12 December 2020

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hy

1 reference

12 December 2020

Valsartan: a novel angiotensin type 1 receptor antagonist

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

1 reference

12 December 2020

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension

1 reference

12 December 2020

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

12 December 2020

10.2165/00003495-200868030-00008

Identifiers

DOI

1 reference

18 August 2017

1 reference